Ultragenyx Pharmaceutical, Inc. (RARE)
16.07
-0.20
(-1.23%)
USD |
NASDAQ |
Nov 13, 16:00
16.07
0.00 (0.00%)
After-Hours: 19:59
Ultragenyx Pharmaceutical Total Assets (Quarterly) : 1.187B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.187B |
| June 30, 2026 | 1.264B |
| March 31, 2026 | 1.296B |
| December 31, 2025 | 1.532B |
| September 30, 2025 | 1.190B |
| June 30, 2025 | 1.306B |
| March 31, 2025 | 1.312B |
| December 31, 2024 | 1.503B |
| September 30, 2024 | 1.538B |
| June 30, 2024 | 1.618B |
| March 31, 2024 | 1.307B |
| December 31, 2023 | 1.497B |
| September 30, 2023 | 1.238B |
| June 30, 2023 | 1.311B |
| March 31, 2023 | 1.383B |
| December 31, 2022 | 1.552B |
| September 30, 2022 | 1.618B |
| June 30, 2022 | 1.321B |
| March 31, 2022 | 1.384B |
| December 31, 2021 | 1.531B |
| September 30, 2021 | 1.485B |
| June 30, 2021 | 1.512B |
| March 31, 2021 | 1.598B |
| December 31, 2020 | 1.793B |
| September 30, 2020 | 1.268B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.314B |
| March 31, 2020 | 1.233B |
| December 31, 2019 | 1.143B |
| September 30, 2019 | 879.94M |
| June 30, 2019 | 958.93M |
| March 31, 2019 | 1.008B |
| December 31, 2018 | 719.56M |
| September 30, 2018 | 765.14M |
| June 30, 2018 | 806.02M |
| March 31, 2018 | 817.35M |
| December 31, 2017 | 490.75M |
| September 30, 2017 | 435.05M |
| June 30, 2017 | 497.54M |
| March 31, 2017 | 545.82M |
| December 31, 2016 | 540.63M |
| September 30, 2016 | 515.17M |
| June 30, 2016 | 481.95M |
| March 31, 2016 | 524.18M |
| December 31, 2015 | 559.57M |
| September 30, 2015 | 602.13M |
| June 30, 2015 | 343.00M |
| March 31, 2015 | 355.84M |
| December 31, 2014 | 197.97M |
| September 30, 2014 | 210.93M |
| June 30, 2014 | 162.59M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.913B |
| AbbVie, Inc. | 147.68B |
| Krystal Biotech, Inc. | 1.586B |
| BridgeBio Pharma, Inc. | 2.162B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.556B |
| Shareholders Equity (Quarterly) | -376.00M |
| Debt to Equity Ratio | -3.154 |
| Current Ratio | 1.398 |
| Net Debt Paydown Yield | -3.96% |